ORIC Pharmaceuticals Inc
ORIC
Get informed when a big investor buys or sells
+ FollowMarket Cap$878.86M
Close$
$0.39
95.9% downside
Current Fair Value
95.9% downsideOvervalued by 95.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $878.86 Million |
|---|---|
| Enterprise Value | $822.47 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.47 |
| Beta | 1.06 |
| Outstanding Shares | 105,472,766 |
Return
| Return on Equity | -32.54% |
|---|---|
| Return on Assets | -30.96% |
| Return on Invested Capital | -34.88% |
Valuation & Multiples
| P/E Ratio | -6.62 |
|---|---|
| PEG | -34.6 |
| Price to Sales | - |
| Price to Book Ratio | 3.14 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -5.63 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 11, 2026
EPS Estimate
$-0.33
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.9262▲ 92.62% |
|---|---|
| Total Calls | 81,300▲ 75.22% |
| Total Puts | 75,300▲ Infinity% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 135.95%▲ 15.03% |
|---|---|
| Total Invested | $1.51B▲ 54.13% |
| Investors Holding | 185▲ 18.00% |
ESG Score
No data
About ORIC Pharmaceuticals Inc
CEO: Jacob Chacko